ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Nephrology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

26,402Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 769

$2.2M Total Retail Price of All Prescriptions

Rank: 6 out of 769

1,032 Patients Receiving at Least One Drug in Part D
90% Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in California
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

1% of this provider’s 1,032 patients filled at least one prescription for a schedule two drug, compared to an average of 1%.

Schedule Three
Controlled Substances

8% of this provider’s 1,032 patients filled at least one prescription for a schedule three drug, compared to an average of 5%.

Brand Name Drugs

41% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $121 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 14.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in California
CLOPIDOGREL 1,183 1,154 258 1 26
AMLODIPINE BESYLATE 1,096 1,000 245 2 1
LOVAZA 583 562 110 3 46
FAMOTIDINE* 555 525 239 4 38
NAMENDA 528 523* 112 5 47
ATORVASTATIN CALCIUM 520 493 153 6 10
PREDNISONE 513 469 274 7 30
LIDODERM 497 478 164 8 52
SIMVASTATIN 448 426 106 9 5
DIOVAN 446 427 82 10 19
ISOSORBIDE MONONITRATE ER 431 411 81 11 43
LOSARTAN POTASSIUM 430 410 125 12 6
METOCLOPRAMIDE HCL 417 392 167 13 94
TAMSULOSIN HCL 412 394 113 14 25
METOPROLOL SUCCINATE 407 357 97 15 24
MELOXICAM 389 357 191 16 81
ALENDRONATE SODIUM 327 322* 84 17 42
TRIAMCINOLONE ACETONIDE 325 294 150 18 84
AZITHROMYCIN 325 310 225 18 63
LEVOTHYROXINE SODIUM 320 296 79 20 13
CRESTOR 320 315* 77 20 41
METFORMIN HCL 319 304 73 22 22
AVODART 314 309* 70 23 90
PIOGLITAZONE HCL 298 293* 67 R 24 67
JANUVIA 283 278* 58 25 35
BENICAR 264 259* 47 26 79
ATENOLOL 260 243 66 27 23
LEVOCETIRIZINE DIHYDROCHLORIDE 255 240 157 28 155
MONTELUKAST SODIUM 254 249* 87 29 68
FUROSEMIDE 240 201 77 30 2
OMEPRAZOLE 235 211 96 31 8
RAPAFLO 230 230 41 32 160
CELEBREX 228 223* 63 33 51
NAPHAZOLINE HCL 228 223* 125 33 242
AMOXICILLIN 227 216 146 35 110
HYDROCHLOROTHIAZIDE 226 213 74 36 27
NEXIUM 222 217* 46 37 34
DEXILANT 221 221 48 38 70
EVISTA 218 213* 50 39 134
GLYBURIDE-METFORMIN HCL 217 212* 38 R 40 144
GABAPENTIN 205 192 78 41 21
BYSTOLIC 190 190 34 42 62
CEPHALEXIN 187 173 122 43 143
CIPROFLOXACIN HCL 184 163 137 44 92
DONEPEZIL HCL 178 178 43 45 49
VOLTAREN 172 167* 74 46 78
POLYETHYLENE GLYCOL 3350 167 150 88 47 119
HYDROCODONE-ACETAMINOPHEN 158 110 75 S3 48 15
ONGLYZA 157 152* 25 49 190
PROAIR HFA 157 152* 76 49 82
PANTOPRAZOLE SODIUM 156 151* 39 51 31
CARVEDILOL 154 138 33 52 11
PATANOL 149 144* 57 53 164
DICLOFENAC SODIUM 145 131 90 54 194
AMOX TR-POTASSIUM CLAVULANATE 145 132 110 54 170
FLUTICASONE PROPIONATE 138 125 77 56 83
MECLIZINE HCL 138 133* 93 56 116
ALLOPURINOL 137 132* 43 58 12
CREON 135 130* 63 59 86
LYRICA 129 111 52 60 101
IBUPROFEN 125 108 91 61 109
LORAZEPAM 122 117* 53 B 62 54
FLUOCINONIDE 120 106 51 63 183
TEKTURNA 118 118 15 64 174
LANTUS SOLOSTAR 118 113* 24 64 106
AZOR 117 112* 19 66 162
AMMONIUM LACTATE 117 112* 60 66 308
FINASTERIDE 111 96 30 68 105
ZOLPIDEM TARTRATE 107 93 42 69 29
AMIODARONE HCL 106 106 22 70 117
CLOBETASOL PROPIONATE 106 101* 61 70 209
HYDROXYZINE HCL 100 95* 45 R 72 161
ACTONEL 98 93* 19 73 163
LISINOPRIL 94 76 25 74 4
NEOMYCIN-POLYMYXIN-DEXAMETH 94 89* 61 74 327
CARBIDOPA-LEVODOPA 90 85* 17 76 154
AMITIZA 88 88 29 77 130
AZELASTINE HCL 85 80* 57 78 252
WELCHOL 83 78* 20 79 169
EFFIENT 79 74* 22 80 337
URSODIOL 79 74* 17 80 253
GLIPIZIDE 78 73* 24 82 32
BD ULTRA-FINE PEN NEEDLE 77 72* 18 83 104
COLCRYS 76 71* 29 84 121
WARFARIN SODIUM 76 71* 14 84 33
CLOTRIMAZOLE-BETAMETHASONE 75 70* 45 86 206
BENAZEPRIL HCL 74 63 21 87 28
RENVELA 72 28 12 88 3
LEVOFLOXACIN 72 67* 55 88 74
MEGESTROL ACETATE 70 65* 39 R 90 71
TRADJENTA 69 64* 16 91 138
SOTALOL 68 68 22 92 353
PROCTOZONE-HC 68 63* 41 92 218
POTASSIUM CHLORIDE 68 63* 32 92 37
PATADAY 67 67 34 95 181
ROPINIROLE HCL 66 61* 33 96 127
NIFEDIPINE ER 65 60* 17 97 20
LOSARTAN-HYDROCHLOROTHIAZIDE 64 64 17 98 72
ULORIC 62 57* 18 99 60
ADVAIR DISKUS 61 61 24 100 93
CLONIDINE HCL 60 38 27 101 17
METHIMAZOLE 59 54* 12 102 374
IBANDRONATE SODIUM 59 59 22 102 128
DILTIAZEM 24HR CD 59 54* 15 102 266
NASONEX 59 54* 26 102 137
PROMETHAZINE VC 58 53* 50 R 106 377
DIGOX 58 53* 25 106 147
NYSTATIN 55 50* 35 108 180
EXFORGE 55 <11 <11 108 108
TRIAZOLAM 54 49* 27 B 110 224
CYCLOBENZAPRINE HCL 51 34 24 R 111 186
SULFAMETHOXAZOLE-TRIMETHOPRIM 51 46* 45 111 87
SPIRIVA 51 37 13 111 139
VALSARTAN-HYDROCHLOROTHIAZIDE 50 45* 11 114 80
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 8, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.